Metabolic and bariatric surgery in mild obesity: mid-term outcomes and safety in an Asian population - Takeaways - MDSpire

Metabolic and bariatric surgery in mild obesity: mid-term outcomes and safety in an Asian population

  • By

  • Wanying Zhong

  • Lijun Chen

  • Yuanhao Huang

  • Dalong Zhu

  • Wenjuan Tang

  • Yuqin Ouyang

  • Xuehui Chu

  • Wenhuan Feng

  • May 20, 2026

  • 0 min

Share

  • 1

    Metabolic and bariatric surgery (MBS) is effective for mild obesity in Asian patients, showing comparable metabolic improvements to higher-BMI counterparts.

  • 2

    Patients with mild obesity achieved lower total weight loss (20%) compared to those with higher BMI (26%), but similar rates of metabolic endpoint achievement.

  • 3

    Both mild and higher-BMI groups showed significant remission rates for type 2 diabetes, hypertension, and other obesity-related comorbidities.

  • 4

    A greater proportion of patients with mild obesity achieved normalization of body weight (BMI <24 kg/m²) post-surgery.

  • 5

    The study suggests MBS is safe for mild obesity, with low complication rates, warranting further research on long-term outcomes and broader surgical indications.

Original Source(s)

Metabolic and bariatric surgery in mild obesity: mid-term outcomes and safety in an Asian population

  • by Wanying Zhong, Lijun Chen, Yuanhao Huang, Dalong Zhu, Wenjuan Tang, Yuqin Ouyang, Xuehui Chu, Wenhuan Feng

  • May 20, 2026

Related Content

Semaglutide Linked to NAION Risk

A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.

Early Enteral Feeding Tied to Fewer Complications

Benefit driven by fewer infections and pulmonary events, though overall complication rates were similar

Estimating the Bariatric Surgery Rate in the Potentially Eligible Population within the Brazilian Public Healthcare System, 2017–2023